8 months initially, then 1-year renewals if you've lost at least 5% of your pre-GLP-1 baseline weight and continue lifestyle modification
Tiziani S,Verma A,Konopleva M
Generally, tirzepatide may be prescribed to obese patients (defined as having a BMI of 30 or higher) or overweight patients (with a BMI of 27 or higher) who also have a weight-related health condition, such as high cholesterol or sleep apnea
If you have had allergic reactions to GLP-1 receptor agonists, this treatment may not be recommended
You're likely to discover these brands as you're researching the top options on the market, so this guide is designed to help you compare the key product details (like third-party testing and dosage), as well as the pros, cons, and pricing